Some researches found that the intra-tumoural and inter-tumoural distribution of DLL3 protein in SCLC is homogeneous [20], supporting the conclusion that biopsy specimens are a reliable source for DLL3 evaluation for targeted therapy. The gene discussed is DLL3; the disease is small cell lung carcinoma.